ConductScience.org, home

Paper29675604

Long-term natural history of liver disease in patients with chronic hepatitis B virus infection: an analysis using the Markov chain model.

Tada T and 5 others. J Gastroenterol, 2018. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Long-term natural history of liver disease in patients with chronic hepatitis B virus infection: an analysis using the Markov chain model. Papers, record 29675604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29675604

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Long-term natural history of liver disease in patients with chronic hepatitis B virus infection: an analysis using the Markov chain model.
PubMed
Journal
J Gastroenterol
PubMed
Year
2018
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
0.87
iCite
Revised in PubMed
2026-10-12
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tada TToshifumi
2Kumada TTakashi
3Toyoda HHidenori
4Ohisa MMasayuki
5Akita TTomoyuki
6Tanaka JJunko

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis B, ChronicMajor topic
Liver CirrhosisMajor topic
Adult
Age Factors
Aged
Carcinoma, Hepatocellular
Disease Progression
Female
Follow-Up Studies
Hepatitis B Surface Antigens
Hepatitis B e Antigens
Humans
Liver Neoplasms
Male
Markov Chains
Middle Aged
Prognosis
Seroconversion

Source PubMed

Download CSV of topics

References23

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16118576Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan.Lancet1981https://conductscience.org/library/papers/6118576PubMed
28246705Markov models in medical decision making: a practical guide.Med Decis Making1993https://conductscience.org/library/papers/8246705PubMed
3212785Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association.Prog Med Virol1978https://conductscience.org/library/papers/212785PubMed
420648555A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B.Hepatology2010https://conductscience.org/library/papers/20648555PubMed
525165830The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis.PLoS One2014https://conductscience.org/library/papers/25165830PubMed
63294348Markov models of natural history.J Clin Epidemiol1988https://conductscience.org/library/papers/3294348PubMed
720034030Alcoholic liver disease.Hepatology2010https://conductscience.org/library/papers/20034030PubMed
818096267Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors.J Hepatol2008https://conductscience.org/library/papers/18096267PubMed
92831148Epidemiology of hepatocellular carcinoma.Gastroenterol Clin North Am1987https://conductscience.org/library/papers/2831148PubMed
1021374666Management of hepatocellular carcinoma: an update.Hepatology2011https://conductscience.org/library/papers/21374666PubMed
1115332272Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.J Med Virol2004https://conductscience.org/library/papers/15332272PubMed
1220586808Clinical Practice Guidelines for Hepatocellular Carcinoma - The Japan Society of Hepatology 2009 update.Hepatol Res2010https://conductscience.org/library/papers/20586808PubMed
1311576642Determination of hepatitis B virus genotype G by polymerase chain reaction with hemi-nested primers.J Virol Methods2001https://conductscience.org/library/papers/11576642PubMed
1426566064AASLD guidelines for treatment of chronic hepatitis B.Hepatology2016https://conductscience.org/library/papers/26566064PubMed
1519918971Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B.Hepatology2010https://conductscience.org/library/papers/19918971PubMed
1627062182Incidence of hepatocellular carcinoma in untreated subjects with chronic hepatitis B: a systematic review and meta-analysis.Liver Int2016https://conductscience.org/library/papers/27062182PubMed
1726201469Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.Hepatol Int2012https://conductscience.org/library/papers/26201469PubMed
187863398Hepatitis viruses and hepatocellular carcinoma.S Afr Med J1994https://conductscience.org/library/papers/7863398PubMed
1911131465Hepatitis B genotypes and the response to interferon therapy.J Hepatol2000https://conductscience.org/library/papers/11131465PubMed
2027394647The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.Lancet2016https://conductscience.org/library/papers/27394647PubMed

See all 23 referencesDownload CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
37580466Application and Effectiveness of Chinese Medicine in Regulating Immune Checkpoint Pathways.Chin J Integr Med2023https://conductscience.org/library/papers/37580466PubMed
37430256
Establishment of a multi-parameter prediction model for the functional cure of HBeAg-negative chronic hepatitis B patients treated with pegylated interferonα and decision process based on response-guided therapy strategy.
BMC Infect Dis2023https://conductscience.org/library/papers/37430256PubMed
37137846[Early antiviral treatment response in HBeAg-positive chronic HBV infected-patients with high viral load and normal ALT].Zhonghua Gan Zang Bing Za Zhi2023https://conductscience.org/library/papers/37137846PubMed
37115242Monitoring of blood biochemical markers for periprosthetic joint infection using ensemble machine learning and UMAP embedding.Arch Orthop Trauma Surg2023https://conductscience.org/library/papers/37115242PubMed
36756119Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients.Front Immunol2023https://conductscience.org/library/papers/36756119PubMed
36148219Interferon add-on therapy increased clinical cure significantly for interferon-experienced chronic hepatitis B patients with low HBsAg.Front Immunol2022https://conductscience.org/library/papers/36148219PubMed
35958609Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients.Front Immunol2022https://conductscience.org/library/papers/35958609PubMed
35835530Multistate Markov model application for blood pressure transition among the Chinese elderly population: a quantitative longitudinal study.BMJ Open2022https://conductscience.org/library/papers/35835530PubMed
35792921Blood pressure states transitions among bus drivers: the application of multi-state Markov model.Int Arch Occup Environ Health2022https://conductscience.org/library/papers/35792921PubMed
34887645Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases.World J Gastroenterol2021https://conductscience.org/library/papers/34887645PubMed
34869415Incidence and Influencing Factors of New Hepatitis B Infections and Spontaneous Clearance: A Large-Scale, Community-Based Study in China.Front Med (Lausanne)2021https://conductscience.org/library/papers/34869415PubMed
33664363The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017.Sci Rep2021https://conductscience.org/library/papers/33664363PubMed
32974760Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?J Gastroenterol2020https://conductscience.org/library/papers/32974760PubMed
32185517Adverse events of nucleos(t)ide analogues for chronic hepatitis B: a systematic review.J Gastroenterol2020https://conductscience.org/library/papers/32185517PubMed
31318913A model of functional thyroid disease status over the lifetime.PLoS One2019https://conductscience.org/library/papers/31318913PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29675604

GET https://conductscience.org/api/papers/v1/29675604/references?page=2